THAR (tharimmune.com) Kacepetan wutah bathi saben saham ing taun lumaku
Risks of early-stage test failures and capital shortages are driving high volatility for Tharimmune, Inc. (THAR). The year-over-year change in EPS demonstrates profit dynamics, where the 0.00 metric serves as the target level. Precision oncology and antibody development provide leadership potential, while the implementation of laboratory robotics with predictive data analytics accelerates the discovery of new molecules.
Rincian analitis lan laporan data perusahaan Tharimmune (THAR)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Tharimmune, Inc.|THAR - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Tharimmune|THAR - Gunggung utang perusahaan|Utang-utang marang aset resik Tharimmune, Inc.|THAR - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Tharimmune|Indikator likuiditas cepet tharimmune.com
- indikator bathi lan kelipatan valuasi:
THAR - Penghasilan resik|Proyeksi bathi mangsa ngarep Tharimmune, Inc.|THAR - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Tharimmune, Inc.|THAR - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Tharimmune Inc|THAR - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Tharimmune|THAR - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan tharimmune.com|THAR - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Tharimmune, Inc.
- informasi babagan volume dodolan lan pendapatan:
Pambiji fundamental:THAR - Tharimmune Corporation
Monopoly pricing within the orphan disease niche provides Tharimmune, Inc. (THAR) with high financial stability. This foundation is reflected in the earnings per share dynamics, measuring the percentage deviation of the current EPS from last year's figures. This metric allows investors to filter out market noise and assess the real efficiency of the business. Growth in this parameter confirms the asset's liquidity. By analyzing the level of relative EPS change over the year, an investor can timely recognize the risk of overpaying for the asset.
Pesaing utama
Kacepetan wutah bathi saben saham ing taun lumaku BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku revmed.com RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi resik saben saham ing taun iki CG Oncology CGON|Wutah bathi saben saham ing taun lumaku UroGen URGN|Prakiraan wutah bathi resik saben saham ing taun iki Bicara Bio (BCAX)|PSNL - Wutah bathi saben saham ing taun lumaku|ERAS - Wutah bathi ing taun lumaku|DCTH: Wutah bathi ing taun lumaku|Y-mAbs Therapeutics, Inc. (YMAB) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki AURA|Kacepetan wutah bathi saben saham ing taun lumaku candeltx.com CADL|Wutah bathi ing taun lumaku ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ACTU (Actuate Therapeutics Inc)|Tambahing bathi saben saham ing taun lumaku CTOR|tuhurabio.com - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Wutah bathi saben saham ing taun lumaku|WHWK - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku tscan.com|CSBR: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku XBiotech USA (XBIT)|CVM: Dinamika bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku ostherapies.com OSTX|Wutah bathi resik saben siji saham kanggo taun lumaku RADX (Radiopharm Theranostics Limited)|Artiva - Wutah bathi ing taun lumaku|ANL: Wutah bathi saben saham ing taun lumaku|VERU: Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku renovarobio.com RENB|Wutah bathi saben saham ing taun lumaku muraloncology.com (MURA)|Wutah bathi resik saben siji saham kanggo taun lumaku KAPA|Wutah bathi ing taun lumaku OKUR (onkuretherapeutics.com)|Wutah bathi resik saben siji saham kanggo taun lumaku GDTC (CytoMed)|Curis - Wutah bathi ing taun lumaku|APLM: Wutah bathi saben saham ing taun lumaku|ADVB: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku SBFM|Wutah bathi ing taun lumaku XBIO|Wutah bathi resik saben saham ing taun iki Salarius Pharmaceuticals SLRX|Wutah bathi ing taun lumaku PPBT (Purple Biotech Ltd)|AONC - Wutah bathi resik saben saham ing taun iki|BGNE: Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun iki Checkpoint Therapeutics, Inc CKPT|ELEV: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku iCAD Inc. (ICAD)|IKNA (Ikena) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Notable Labs (NTBL)|Wutah bathi ing taun lumaku VIRX|Wutah bathi resik saben saham ing taun iki MorphoSys Corporation MOR|NAYA Biosciences - Wutah bathi resik saben saham ing taun iki|Owah-owahan bathi resik saben saham ing taun lumaku Ascentage Pharma
